Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies-Reference-Cited by-同舟云学术

Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies

Published:2021-07-06 Issue:9 Volume:100 Page:2381-2385
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Cao Junjie^ORCID,Pei Renzhi,Zhang Pisheng,Liu Xuhui,Chen Dong,Du Xiaohong,Chen Lieguang,Wang Tiantian,Ye Peipei,Lu Ying

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-021-04497-w.pdf

Reference22 articles.

1. Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, Tan AM, Sanpakit K, Li CF, Lee AC, Chua HC, Okamoto Y (2013) Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol 162(3):383–391. https://doi.org/10.1111/bjh.12405

2. Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, Peffault de Latour R, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulasekararaj A, Marsh JC, Samarasinghe S (2015) Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol 171(4):585–594. https://doi.org/10.1111/bjh.13614

3. Zhang P, Feng K, Xue Y, Zhang CX, Wang Y, Li XL (2017) Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia. Eur Rev Med Pharmacol Sci 21(1):155–161

4. Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH (2011) Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant 17(3):291–299. https://doi.org/10.1016/j.bbmt.2010.10.028

5. Xu LP, Jin S, Wang SQ, Xia L-H, Bai H, Gao S-J, Liu Q-F, Wang J-M, Wang X, Jiang M, Zhang X, Wu D-P, Huang X-J (2017) Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10(25):25–34. https://doi.org/10.1186/s13045-017-0398-y

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond;Blood;2023-01-05

2. Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate’s antibody profile for donor selection;Human Immunology;2022-10